SK Chemicals advocates vaccine security

Published: 2010-08-16 06:57:00

Updated: 2010-08-16 06:57:00

When the influenza A (H1N1) fear swept the world last year, Koreans were relieved over the domestic availability of vaccines. Green Cross Korea produced the vaccine "Green Flu S" in December.

This time, SK Chemicals is taking all efforts to ensure vaccine safety for people’s health.

SK Chem...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK